Charles Whalen
Hematology & Oncology · Fort Wayne, INNPI 1245232156
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.8% of the total across 146 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 41 manufacturers, the largest accounting for just 11.6% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for hematology & oncology clinicians in IN, where the typical reported total is $3,829.
Across 146 payments — averaging $23.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$389
- Takeda Pharmaceuticals U.S.A., Inc.$279
- Sanofi$279
- Merck$227
- Pharmacyclics LLC, An Abbvie Company$222
- AstraZeneca$198
- plus $2K from 35 others
What the payments were for
- Food & beverage$3,32199%
- Education$391%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 11 | $389 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $279 |
| Sanofi | 15 | $279 |
| Merck | 15 | $227 |
| Pharmacyclics LLC, An Abbvie Company | 10 | $222 |
| AstraZeneca(2 entities) | 5 | $198 |
| GSK | 3 | $161 |
| Eisai Inc. | 4 | $156 |
| Genentech USA, Inc. | 3 | $153 |
| Amgen | 9 | $140 |
| Novartis | 8 | $134 |
| Exelixis Inc. | 3 | $116 |
| Pfizer | 8 | $111 |
| Bristol Myers Squibb | 6 | $100 |
| Incyte Corporation | 5 | $83 |
| E.r. Squibb & Sons, L.L.C. | 4 | $70 |
| Regeneron Healthcare Solutions, Inc. | 3 | $51 |
| Tersera Therapeutics LLC | 2 | $41 |
| Daiichi Sankyo Inc. | 2 | $39 |
| Gilead | 3 | $39 |
| Lilly USA, LLC | 2 | $28 |
| Beigene USA, Inc. | 2 | $27 |
| Adaptive Biotechnologies Corporation | 1 | $26 |
| AbbVie | 2 | $25 |
| Rigel Pharmaceuticals, Inc. | 1 | $20 |
| Taiho Oncology, Inc. | 1 | $19 |
| Aadi Bioscience, Inc. | 1 | $19 |
| Puma Biotechnology, Inc. | 1 | $19 |
| Novocure Inc. | 1 | $18 |
| Immunogen, Inc. | 1 | $17 |
| Dova Pharmaceuticals | 1 | $17 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $17 |
| Astellas Pharma US Inc | 1 | $15 |
| Bayer | 1 | $15 |
| Agios Pharmaceuticals, Inc. | 1 | $14 |
| Acrotech Biopharma Inc. | 1 | $14 |
| Array Biopharma Inc | 1 | $14 |
| Foundation Medicine, Inc. | 1 | $13 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
| Sanofi-aventis U.S. LLC | 1 | $12 |
| Seagen Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,360 in reported general payments places this provider in the 45th percentile of 224 hematology & oncology providers in Indiana.
Other hematology & oncology in Fort Wayne
- Ahad SadiqFort Wayne$430K
- Zhentao ZhangFort Wayne$167K
- Sreenivasa NattamFort Wayne$120K
- Praveen KolliparaFort Wayne$88K
- Dolly Quispe LeveauFort Wayne$74K
- Matthew CarrFort Wayne$51K
- Shalini ChitneniFort Wayne$46K
- Ryan GonzalesFort Wayne$38K
- Robert MangesFort Wayne$31K
- Michael TooleFort Wayne$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.